ATE165597T1 - 1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen - Google Patents
1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranenInfo
- Publication number
- ATE165597T1 ATE165597T1 AT92200159T AT92200159T ATE165597T1 AT E165597 T1 ATE165597 T1 AT E165597T1 AT 92200159 T AT92200159 T AT 92200159T AT 92200159 T AT92200159 T AT 92200159T AT E165597 T1 ATE165597 T1 AT E165597T1
- Authority
- AT
- Austria
- Prior art keywords
- oleoylazacycloheptanone
- biological membranes
- drugs containing
- enhance transport
- oleylazacycloheptan
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- RAGAJCBPQFVUJU-KTKRTIGZSA-N 1-[(z)-octadec-9-enyl]azepan-2-one Chemical compound CCCCCCCC\C=C/CCCCCCCCN1CCCCCC1=O RAGAJCBPQFVUJU-KTKRTIGZSA-N 0.000 abstract 1
- -1 1-oleylazacycloheptan-2-one compound Chemical class 0.000 abstract 1
- 229940122627 Membrane permeability enhancer Drugs 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 210000004955 epithelial membrane Anatomy 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92200159A EP0552504B1 (de) | 1992-01-20 | 1992-01-20 | 1-Oleoylazacycloheptanon(2) enthaltende Arzneimittel zur Verstärkung des Transports durch biologische Membranen |
| HK98104161A HK1005063A1 (en) | 1992-01-20 | 1998-05-14 | Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165597T1 true ATE165597T1 (de) | 1998-05-15 |
Family
ID=26131246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92200159T ATE165597T1 (de) | 1992-01-20 | 1992-01-20 | 1-oleoylazacycloheptanon(2) enthaltende arzneimittel zur verstärkung des transports durch biologische membranen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0552504B1 (de) |
| AT (1) | ATE165597T1 (de) |
| DE (1) | DE69225306T2 (de) |
| ES (1) | ES2114907T3 (de) |
| HK (1) | HK1005063A1 (de) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1343426A (en) * | 1971-05-07 | 1974-01-10 | Dow Corning Tld | Acylated lactams |
| US4461638A (en) * | 1975-06-19 | 1984-07-24 | Nelson Research & Development Company | Delivery of plant nutrients |
| DE2616993A1 (de) * | 1976-04-17 | 1977-10-27 | Bayer Ag | Verfahren zum faerben von flaechengebilden |
| US4310525A (en) * | 1981-01-23 | 1982-01-12 | Nelson Research & Development Company | Method of treatment of inflammation |
| US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| DE3786199T2 (de) * | 1986-04-03 | 1993-09-23 | Hercon Lab | Artikel fuer die verabreichung pharmakologisch aktiver substanzen. |
| US4755535A (en) * | 1986-04-23 | 1988-07-05 | Nelson Research & Development Co. | Compositions comprising 1-substituted azacycloalkenes |
| ES2038154T3 (es) * | 1986-11-19 | 1993-07-16 | Whitby Research, Inc. | Un procedimiento para preparar una composicion para potenciar la penetracion de membranas de al menos un agente sistematicamente activo. |
| US4879275A (en) * | 1987-09-30 | 1989-11-07 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agent |
| CA1334646C (en) * | 1988-04-08 | 1995-03-07 | James Vanolden Peck | Transdermal penetration enhancers |
-
1992
- 1992-01-20 AT AT92200159T patent/ATE165597T1/de not_active IP Right Cessation
- 1992-01-20 ES ES92200159T patent/ES2114907T3/es not_active Expired - Lifetime
- 1992-01-20 DE DE69225306T patent/DE69225306T2/de not_active Expired - Fee Related
- 1992-01-20 EP EP92200159A patent/EP0552504B1/de not_active Expired - Lifetime
-
1998
- 1998-05-14 HK HK98104161A patent/HK1005063A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0552504A1 (de) | 1993-07-28 |
| DE69225306T2 (de) | 1998-12-17 |
| HK1005063A1 (en) | 1998-12-18 |
| DE69225306D1 (de) | 1998-06-04 |
| ES2114907T3 (es) | 1998-06-16 |
| EP0552504B1 (de) | 1998-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69317494D1 (de) | Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten | |
| BR9611096B1 (pt) | composição farmacêutica compreendendo um extrato estável de hypericum perforatum l. | |
| SE8700499D0 (sv) | Novel pharmacologically active compounds | |
| NO952321D0 (no) | Polypeptid, samt anti-HIV-preparat fremstilt fra dette | |
| DE59306544D1 (de) | Verwendungen von alpha-Hydroxyfettsäuren | |
| DE68909139D1 (de) | Substanz FR901228 und deren Herstellung. | |
| EP1449921A3 (de) | Neuartige, biologisch aktive Polypeptide, ihre Herstellung und diese Polypeptide enthaltende pharmazeutische Zusammensetzung | |
| EP0221041A3 (de) | Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung | |
| HUP9903536A2 (hu) | Bázikus anyaggal stabilizált gyógyászati készítmények | |
| HUP0000589A2 (hu) | Vizes peptid készítmények | |
| ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
| EP0173664A3 (de) | Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung | |
| DE59008356D1 (de) | Heterocyclische Verbindungen. | |
| MD1360B2 (en) | A fungicidal composition, process for control and prevention of plants Oomycetes infection | |
| EA199901012A1 (ru) | Фармацевтические композиции на основе тизоксанида и нитазоксанида | |
| MY129946A (en) | Compound with gastric acid inhibitory effect and process for its preparation. | |
| SE8600658D0 (sv) | Novel composition of matter | |
| DE69225306D1 (de) | 1-Oleoylazacycloheptanon(2) enthaltende Arzneimittel zur Verstärkung des Transports durch biologische Membranen | |
| DK0397646T3 (da) | Farmaceutisk præparat til behandling af leversygdomme | |
| DK344489D0 (da) | Substituerede 2-imidazoliner og fremstilling og anvendelse deraf | |
| DK0853476T5 (da) | Nimesulidholdigt farmaceutisk præparat til topisk anvendelse | |
| KR920018076A (ko) | 신규 폴리펩티드 | |
| ATE15189T1 (de) | Guanidine, verfahren zur herstellung und pharmazeutische praeparate enthaltend solche verbindungen. | |
| EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
| RU92015628A (ru) | Состав для дезинфекции объектов пчеловодства |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |